Updates are available Correction dated 2021-09-01
Click to view Correction: https://doi.org/10.1038/s41584-021-00690-3
-
Authors
Barber, Megan R. W. https://orcid.org/0000-0003-1055-1335
Drenkard, Cristina https://orcid.org/0000-0002-6832-7291
Falasinnu, Titilola
Hoi, Alberta https://orcid.org/0000-0002-9416-7383
Mak, Anselm https://orcid.org/0000-0002-4688-7829
Kow, Nien Yee https://orcid.org/0000-0002-5492-3172
Svenungsson, Elisabet https://orcid.org/0000-0003-3396-3244
Peterson, Jonna https://orcid.org/0000-0001-6585-892X
Clarke, Ann E. https://orcid.org/0000-0002-3112-9646
Ramsey-Goldman, Rosalind https://orcid.org/0000-0001-8712-787X
- License Information
-
More Information
Article History
Accepted: 9 July 2021
First Online: 3 August 2021
Change Date: 1 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41584-021-00690-3
Competing interests
: A.E.C. has received consulting fees from AstraZeneca, Exagen Diagnostics and GlaxoSmithKline. A.M. has received consulting fees from Janssen and research grants from GlaxoSmithKline and Janssen. C.D. is supported by a GlaxoSmithKline award (ID 0000048412). E.S. has received honoraria from Janssen and Lilly. R.R.-G. has received research grants from Exagen Diagnostics and consulting fees from Thermo Fisher Scientific and Aurinia Pharmaceuticals. A.H. has received honoraria from AstraZeneca, Janssen and AbbVie, and research grant from Merck Serono. M.R.W.B has received consulting fees from AbbVie, Janssen, GlaxoSmithKline and Sanofi Genzyme. All other authors declare no competing interests.
